Showing 11-15 of 24 news & articles:
Artificial Intelligence for Real-World Evidence

Published on HealthEconomics.com on January 3, 2018   As artificial intelligence (AI) and Big Data are lauded for their potential uses in life sciences and healthcare, it is becoming difficult to differentiate between the myriad of terms and technologies and their real value in advancing real-world evidence (RWE).   In this article, we explore key AI[…]

Big Data Reveals 1 out of 6 ER Visits in Q2 2017 Opioid Related

BIG DATA REVEALS 1 OUT OF 6 ER VISITS IN Q2 2017 OPIOID RELATED OM1 launches a prototype for tracking the public health crisis in near real time BOSTON, November 27, 2017 — OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced it has[…]

Big Data Analyses of the New ACC/AHA Blood Pressure Guidelines

77% OF ADULT PATIENTS, SEEN BY HEALTHCARE PROVIDERS, NOW HAVE HIGH BLOOD PRESSURE OM1 releases big data analyses of impact of new blood pressure guidelines BOSTON, November 20, 2017 — OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced the release of big data[…]

OM1 Named to CIOReview Top 100 Big Data Providers 2017

BOSTON, August 22, 2017 — OM1 has been recognized by CIOReview Magazine as one of the top 100 most promising big data solution providers in 2017. OM1 was nominated and ultimately selected following CIOReview’s annual comprehensive review process. CIOReview’s editorial team analyzed approximately 1,000 companies that provide big data solutions and are at the forefront[…]

Big Ideas for Big Data Analytics in Real-World Evidence

Published August 9  – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]